X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.64
Delayed Data
As of 11:42am ET
 -0.038 / -2.26%
Today’s Change
1.62
Today|||52-Week Range
4.14
-28.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization7.9K7.0K3.0K1.0K
 
 
 
 
 
 
Operating ExpensesGross Income-7.9K-7.0K-3.0K-1.0K
 
 
 
 
 
General Expenses2.0M2.0M1.7M1.2M
 
 
 
 
 
Research And Development274.1K577.8K444.4K43.3K
 
 
 
 
 
Total Operating Expenses2.0M2.0M1.7M1.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.0M-2.0M-1.7M-1.2M
 
 
 
 
 
Extraordinary Credit--0.000.00770.4K
 
 
Extraordinary Charge---1.6M-850.7K0.00
 
 
 
Interest Expense On Debt5.9K9.0K7.0K339.4K
 
 
 
 
 
Other Expenses-99.6K-12.0K23.1K13.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.1M-3.6M-2.6M-786.5K
 
 
 
 
 
Discontinued Operations-402.2K0.000.000.00
 
 
Extraordinary Items0.00-688.7K0.000.00
 
 
Net Income-2.5M-3.6M-2.6M-786.5K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.3M2.6M2.7M4.7M
 
 
 
 
 
Shares To Calculate EPS Diluted2.3M2.6M2.7M4.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.08-$1.70-$0.90-$0.20
 
 
 
 
 
EPS Diluted-$1.08-$1.40-$0.90-$0.20